Abel Ferrandez

Title: Abel Ferrandez: Innovator in Anticoagulant Detection

Introduction

Abel Ferrandez is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of medical diagnostics, particularly in the detection of anticoagulants. His innovative approach has the potential to enhance the quality of patient care through improved testing methods.

Latest Patents

Abel Ferrandez holds a patent for a novel method titled "Identification of anticoagulants in a sample." This invention focuses on determining inhibitors of proteolytically active coagulation factors, specifically the qualitative detection of direct thrombin and factor Xa inhibitors. The method allows for a qualitative determination of the nature of anticoagulants present in a sample using a single coagulation-based test. This innovation can be utilized in a test kit, including a point-of-care (POC) system, making it a valuable tool in clinical settings.

Career Highlights

Throughout his career, Ferrandez has worked with prominent companies such as Pentapharm AG and DSM IP Assets B.V. His experience in these organizations has contributed to his expertise in the field of anticoagulant detection and medical diagnostics.

Collaborations

Abel Ferrandez has collaborated with Anne Brisset, further enhancing his work in the field. Their partnership has likely fostered innovative ideas and advancements in anticoagulant detection.

Conclusion

Abel Ferrandez is a distinguished inventor whose work in anticoagulant detection has the potential to revolutionize medical diagnostics. His innovative methods and collaborations highlight his commitment to improving patient care through technology.